Akebia Therapeutics to present vadadustat trial results at ASN Kidney Week
Akebia Therapeutics will present VOICE trial results on October 23, comparing vadadustat with an ESA in hemodialysis anemia. The readout will focus on safety outcomes.
Akebia Therapeutics will present VOICE trial results on October 23, comparing vadadustat with an ESA in hemodialysis anemia. The readout will focus on safety outcomes.